132 results
Page 5 of 7
8-K
EX-1.1
b8fjkmbt0w9i6xhsacy2
29 Jul 20
Arcturus Therapeutics Announces Pricing of $173.0 Million Public Offering of Common Stock
6:02am
424B5
wa3lzcdmjda5d0
28 Jul 20
Prospectus supplement for primary offering
4:17pm
8-K
EX-99.1
km95ma6w60o0ywy
24 Jul 20
Israel secures rights to stockpile and reserve doses of LUNAR-COV19 for its citizens
6:02am
8-K
kse26249pow694
24 Jul 20
Israel secures rights to stockpile and reserve doses of LUNAR-COV19 for its citizens
6:02am
8-K
ygxh2yc z3epocaf
18 Jun 20
Regulation FD Disclosure
1:15pm
8-K
EX-99.1
v93ildik
21 May 20
Ultragenyx Announces Exercise of Option to Purchase Additional Stock of Arcturus Therapeutics
4:34pm
8-K
900l2rbqz elvb
7 May 20
Arcturus Therapeutics Announces First Quarter 2020 Financial
4:08pm
8-K
EX-99.1
u2k lje6m5p
7 May 20
Arcturus Therapeutics Announces First Quarter 2020 Financial
4:08pm
424B5
9s481xy5
17 Apr 20
Prospectus supplement for primary offering
4:02pm
8-K
EX-1.1
c014i41 8jdlijva95co
17 Apr 20
Entry into a Material Definitive Agreement
6:06am
424B5
w77jqox3jig 12wnydv
15 Apr 20
Prospectus supplement for primary offering
4:14pm
8-K
EX-10.1
n2oa s05t6uh
27 Mar 20
Entry into a Material Definitive Agreement
5:20pm
424B5
zo75p4r
27 Mar 20
Prospectus supplement for primary offering
5:19pm
10-K
EX-10.1
6c0t3y
16 Mar 20
Annual report
11:09am
10-K
3zq81333y 0w
16 Mar 20
Annual report
11:09am
8-K
psmp5
11 Mar 20
Arcturus Therapeutics Reports Fourth Quarter and Year End 2019 Financial Results
4:05pm